Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Arrhythmias, Cardiac » Tachycardia
Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Cardiac Conduction System Disease » Tachycardia
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Arrhythmias, Cardiac » Tachycardia
Description
Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia. MeSH
Hierarchy View
Subtype Terms (4)
Tachycardia, Paroxysmal
1 approved drug
Tachycardia, Supraventricular
7 approved drugs
Tachycardia, Ventricular
36 drugs (30 approved, 6 experimental)
Approved Indicated Drugs (2)
Phase 4 Indicated Drugs (12)
Phase 3 Indicated Drugs (6)
Phase 2 Indicated Drugs (4)
Phase 1 Indicated Drugs (2)
Other Experimental Indicated Drugs (9)
Organization Involved with Phase 4 Indications (46)
Ankara Yildirim Beyazıt University
Canadian Institutes of Health Research (CIHR)
Cardiovascular Consultants of Nevada
Heart and Stroke Foundation of Canada
Hospital General Universitario Gregorio Marañon
Icahn School of Medicine at Mount Sinai
National Center for Advancing Translational Science (NCATS)
Organization Involved with Phase 3 Indications (24)
Organization Involved with Phase 2 Indications (18)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (19)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
